Year: 2019
Type: review
Abstract: Purpose: Humans are increasingly exposed to ionizing radiation (IR).Both low (<100 mGy) and high doses can cause stochastic effects, including cancer; whereas doses above 100 mGy are needed to promote tissue or cell damage.10-15% of radiotherapy (RT) patients suffer adverse reactions, described as displaying radiosensitivity (RS).Sensitivity to IR's stochastic effects is termed radiosusceptibility (RSu).To optimize radiation protection we need to understand the range of individual variability and underlying mechanisms.We review the potential mechanisms contributing to RS/RSu focusing on RS following RT, the most tractable RS group.Conclusions: The IR-induced DNA damage response (DDR) has been well characterized.Patients with mutations in the DDR have been identified and display marked RS but they represent only a small percentage of the RT patients with adverse reactions.We review the impacting mechanisms and additional factors influencing RS/RSu.We discuss whether RS/RSu might be genetically determined.As a recommendation, we propose that a prospective study be established to assess RS following RT.The study should detail tumor site and encompass a well-defined grading system.Predictive assays should be independently validated.Detailed analysis of the inflammatory, stress and immune responses, mitochondrial function and life style factors should be included.Existing cohorts should also be optimally exploited.
Institutions: Commissariat à l'Énergie Atomique et aux Énergies Alternatives, CEA Paris-Saclay - Etablissement de Fontenay-aux-roses, Centre National de la Recherche Scientifique, Université Grenoble Alpes, Institute of Nuclear Medicine & Allied Sciences, Inserm, TUM Klinikum, LMU Klinikum, Ludwig-Maximilians-Universität München, Stockholm University, Centre de Recherche sur les Ions, les Matériaux et la Photonique, Université de Caen Normandie, University of Sussex, Université de Nantes, Nantes Université, Belgian Nuclear Research Centre, Université Paris-Saclay
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $2,583
Funder: Agence Nationale de la Recherche
Award: NExT (I-SITE)
OpenAlex ID: W2994680642
